Sclerosteosis 2 has been mapped to the LRP4 gene where there is direct interaction between sclerostin and LRP4, and LRP4 facilitates sclerostin mediated WNT inhibition; which is implicated in LRP4 mutants [26, 27]. This evidence concerns the gene LRP4 and sclerosteosis.